Jamieson Wellness (TSE:JWEL) Lowered to Hold Rating by Canaccord Genuity Group

Jamieson Wellness (TSE:JWEL) was downgraded by investment analysts at Canaccord Genuity Group from a “buy” rating to a “hold” rating in a report issued on Monday,BayStreet.CA reports. They currently have a C$45.75 price objective on the stock, up from their prior price objective of C$44.50. Canaccord Genuity Group’s price target would suggest a potential upside of 0.39% from the stock’s previous close.

A number of other brokerages also recently issued reports on JWEL. Stifel Nicolaus downgraded Jamieson Wellness from a “buy” rating to a “hold” rating and raised their price objective for the stock from C$45.00 to C$45.75 in a research report on Friday. TD cut Jamieson Wellness from a “buy” rating to a “hold” rating and raised their price target for the company from C$48.00 to C$49.00 in a research note on Monday. Canadian Imperial Bank of Commerce cut shares of Jamieson Wellness from an “outperformer” rating to a “tender” rating and upped their target price for the company from C$44.00 to C$45.75 in a report on Friday. Finally, Royal Bank Of Canada downgraded Jamieson Wellness from an “outperform” rating to a “sector perform” rating and decreased their price objective for the company from C$46.00 to C$45.75 in a report on Monday. Two analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Jamieson Wellness has a consensus rating of “Hold” and a consensus target price of C$46.43.

Jamieson Wellness Price Performance

Shares of TSE:JWEL traded up C$0.09 during midday trading on Monday, reaching C$45.57. 310,139 shares of the company’s stock traded hands, compared to its average volume of 100,466. The company has a debt-to-equity ratio of 93.69, a quick ratio of 1.08 and a current ratio of 3.41. The company has a fifty day simple moving average of C$39.62 and a two-hundred day simple moving average of C$36.77. The company has a market cap of C$1.89 billion, a P/E ratio of 26.34 and a beta of 1.48. Jamieson Wellness has a 1 year low of C$32.54 and a 1 year high of C$45.65.

Jamieson Wellness (TSE:JWEL) last released its quarterly earnings data on Thursday, August 6th. The company reported C$0.46 EPS for the quarter. The company had revenue of C$233.84 million during the quarter. Jamieson Wellness had a net margin of 8.92% and a return on equity of 15.93%. Equities analysts predict that Jamieson Wellness will post 2.1438892 EPS for the current fiscal year.

About Jamieson Wellness

Jamieson Wellness Inc is engaged in the manufacturing, distributing, and marketing of branded natural health products, including vitamins, minerals, and supplements. The company operates in two segments: The Jamieson brands and The Strategic Partners. The majority of its revenue comes from the Jamieson brand segment. Some of its brands are Jamieson, Progressive, Precision, and Iron Vegan. Geographically, most of its revenue is derived from the domestic market.